Pelaia G, Maselli R, Gallelli L. Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium. Multidiscip Respir Med [Internet]. 2014 Dec. 8 [cited 2024 Jul. 7];9(1). Available from: https://mrmjournal.org/index.php/mrm/article/view/399